Skip to main content
Contact Us
Subscribe
E-Edition
60°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Joseph Tucker
Recent news which mentions Joseph Tucker
Enveric Biosciences Advances Non-Hallucinogenic DMT Analog Drug With Promising Preclinical Results
November 25, 2024
Tickers
ENVB
NEWS
Tags
Joseph Tucker
Cannabis
premium
From
Benzinga
Enveric Biosciences Trims Losses, Eyes Key Drug Approval For Difficult-To-Treat Mental Health Disorders
November 18, 2024
Tickers
ENVB
NEWS
Tags
premium
Earnings
Joseph Tucker
From
Benzinga
Enveric Biosciences Out-Licenses Key Program To MycoMedica In $62M Deal
November 12, 2024
Tickers
ENVB
NEWS
Tags
News
biotechnology
mental health
From
Benzinga
Enveric Biosciences Advances Testing Of Its Non-Hallucinogenic Psychedelic
October 15, 2024
Tickers
ENVB
NEWS
Tags
Enveric
Enveric Biosciences
Non/Hallucinogenic Psychedelic Compound
From
Benzinga
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
October 04, 2024
Tickers
ATAI
ENVB
NEWS
Tags
Psychedelics 2/0
Srinivas Rao
News
From
Benzinga
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
September 25, 2024
Tickers
CCC
ENVB
NEWS
Tags
News
Psychedelics Research
CCC
From
Benzinga
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
July 25, 2024
Tickers
DMT
ENVB
NEWS
Tags
Psychedelics mental health
News
Benzinga
From
Benzinga
New Patented Psychedelic Drug Brings Hope For Brain Disorder Therapies
July 11, 2024
Tickers
ENVB
Tags
Benzinga
ENVB
Psychedelics
From
Benzinga
'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand
May 16, 2024
Tickers
ENVB
NEWS
Tags
News
psychedelics anxiety
Psychedelic Medication
From
Benzinga
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
May 14, 2024
Tickers
ENVB
NEWS
Tags
News
Microdosing
Novel Psilocin Prodrugs
From
Benzinga
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
May 08, 2024
Tickers
ENVB
NEWS
Tags
Psychedelics
ENVB
Market News
From
Benzinga
Enveric Completes Manufacturing Of Its Psilocin Prodrug To Supply Drug Material For Completion Of Preclinical Program
August 21, 2023
Tickers
ENVB
Tags
Cannabis
Penny Stocks
Joseph Tucker
From
Benzinga
Enveric Unveils Positive Results From Preclinical Studies Supporting Metabolic Profile Of Its Psilocin Prodrug For Anxiety
July 24, 2023
Tickers
ENVB
Tags
News
Psychedelics
Market News
From
Benzinga
Enveric Unveils Positive Results From Animal Studies Of Its Psilocin Prodrug For Anxiety
July 17, 2023
Tickers
ENVB
Tags
News
Psychedelics
ENVB
From
Benzinga
Psychedelics Company Takes 'A Key Step' With New Formulation Of Its Psilocin Prodrug For Anxiety
June 26, 2023
Tickers
ENVB
Tags
News
Psychedelics
Market News
From
Benzinga
Enveric Stock Trading Higher On Notice Of Allowance For Patent Application For Its Carboxylated Psilocybin Derivatives
June 05, 2023
Tickers
ENVB
Tags
Joseph Tucker
Penny Stocks
Cannabis
From
Benzinga
Enveric Stock Soars On Reception Of Notice Of Allowance For Patent Application For Its Psilocin Prodrug Designs
May 24, 2023
Tickers
ENVB
Tags
Psychedelics
ENVB
Market News
From
Benzinga
Enveric Releases Paper Detailing The Development Of Novel Psilocin Prodrugs For The Treatment Of Mental Health Disorders
May 22, 2023
Tickers
ENVB
Tags
Markets
Cannabis
Joseph Tucker
From
Benzinga
Enveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of Psilocin
May 18, 2023
Tickers
ENVB
Tags
News
Benzinga
Psychedelics
From
Benzinga
Enveric Biosciences Q1 Net Loss Of $4.80M, More On Basic And Diluted Loss Per Share
May 15, 2023
Tickers
ENVB
Tags
Akos Biosciences
Markets
Inc/
From
Benzinga
EXCLUSIVE: Reinventing Mental Health & Next-Gen Psychedelics, 'Access And Clinical Data Are Key'
April 14, 2023
Tickers
ENVB
PSYBF
TRYPF
Tags
Evan Levine
Penny Stocks
Events
From
Benzinga
Enveric Biosciences Files Provisional Patent For CBD+Celecoxib Conjugate For Osteoarthritis
February 08, 2022
Tickers
CBD
ENVB
Tags
osteoarthritis
General
News
From
Benzinga
Cannabis Movers & Shakers: NORML, TGOD, Enveric Biosciences, Dalwhinnie Enterprises
December 10, 2021
Tickers
ENVB
TGODF
TLRY
Tags
General
News
TLRY
From
Benzinga
Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction
September 17, 2021
Tickers
ENVB
Tags
David Johnson
Market News
ENVB
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.